"We are particularly excited about the single-cell transcriptomics database we're building with Boehringer Ingelheim to drive research and ... insights across Alexion's Research & Development, ...

“We are particularly excited about the single-cell transcriptomics database we’re building with Boehringer Ingelheim to drive research and ... insights across Alexion’s Research & Development, ...

Boehringer Ingelheim (BI) and Click Therapeutics have ... and also clinical, regulatory, and commercial milestone payments up to in total $460 million, plus tiered royalties.

The non-cystic fibrosis bronchiectasis market is driven by rising prevalence linked to respiratory infections, autoimmune diseases, and COPD. Increasing awareness among healthcare providers and ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...